Skip to main content

and
  1. No Access

    Article

    Use of defibrotide to treat adult patients with transplant-associated thrombotic microangiopathy

    M. E. Martínez-Muñoz, R. Forés, A. Lario, G. Bautista in Bone Marrow Transplantation (2019)

  2. No Access

    Article

    Mesenchymal stromal cells for steroid-refractory acute GvHD

    C Fernández-Maqueda, R Gonzalo-Daganzo, C Regidor in Bone Marrow Transplantation (2017)

  3. No Access

    Article

    Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor

    Low severity of GVHD, substantial graft vs tumor (GVT) and slow development of protective immunity are well-documented features of cord blood transplants (CBT). We have evaluated the immune reconstitution of adul...

    T Martín-Donaire, M Rico, G Bautista, R Gonzalo-Daganzo in Bone Marrow Transplantation (2009)

  4. No Access

    Article

    Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor

    This open label clinical study provides updated evaluation of the strategy of single unit cord blood transplants (CBTs) with co-infusion of third-party donor (TPD) mobilized hematopoietic stem cells (MHSC). Fi...

    G Bautista, J R Cabrera, C Regidor, R Forés in Bone Marrow Transplantation (2009)

  5. No Access

    Article

    Chagas disease in a recipient of cord blood transplantation

    R Forés, I Sanjuán, F Portero, E Ruiz, C Regidor in Bone Marrow Transplantation (2007)

  6. No Access

    Article

    Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms

    The number of infused cells is a very important factor in cord blood transplant (CBT) engraftment. Prior ex vivo expansion of aliquots of transplanted cord blood (CB) units is being investigated as a procedure to...

    MN Fernández, C Regidor, R Cabrera, J García-Marco, M Briz in Bone Marrow Transplantation (2001)

  7. No Access

    Article

    Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma

    A 48-year-old patient with IgA k multiple myeloma received a BMT from his HLA-matched sibling. After transplantation, the disease relapsed. Melphalan therapy followed by reinfusion of haemopoietic blood stem c...

    R Cabrera, F Díaz-Espada, Y Barrios, M Briz, R Forés in Bone Marrow Transplantation (2000)

  8. No Access

    Article

    Rhinocerebral mucormycosis following donor leukocyte infusion: successful treatment with liposomal amphotericin B and surgical debridement

    A 24-year-old male developed cytogenetic relapse of chronic myeloid leukemia (CML) four years after allogeneic BMT. After a year of treatment with IFN-α, he achieved a partial cytogenetic response. Treatment w...

    FJ Peñalver, R Romero, R Forés, R Cabrera, JL Díez-Martin in Bone Marrow Transplantation (1998)

  9. No Access

    Article

    Detection of maternal DNA in umbilical cord blood by polymerase chain reaction amplification of minisatellite sequences

    One of the concerns about the use of cord blood as a source of hematopoietic stem cells for allogeneic transplantation is the possibility of contamination by maternal cells which could cause life-threatening G...

    M Briz, C Regidor, D Monteagudo, N Somolinos, C Garaulet in Bone Marrow Transplantation (1998)

  10. No Access

    Article

    Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange?

    Thrombotic microangiopathy (TMA) is an infrequent but serious complication of allogeneic transplantation. The success rate of plasma exchange (PE) reported in the treatment of this entity is a controversial su...

    P Llamas, R Romero, R Cabrera, I Sanjuán, R Forés in Bone Marrow Transplantation (1997)